S2 Genomics
Biotechnology ResearchCalifornia, United States2-10 Employees
S2 Genomics enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies.
Recent Acquisition S2 Genomics was acquired by Precision Cell Systems in September 2025, indicating potential opportunities for integrated solutions and collaborative approaches within the enhanced corporate structure.
Innovative Product Launch The launch of the SingulatorTM 100 and 200 Systems in October 2023 demonstrates ongoing product innovation, opening avenues for upselling and expanding sales to laboratories seeking automation in single-cell processing.
Strategic Partnerships Partnerships with organizations like Bonsailab and distribution agreements across Europe suggest opportunities to extend market reach and introduce related genomics products to new geographic regions.
Funding & Growth Securing $16 million in Series A funding in January 2024 reflects strong investor confidence and potential for scaling operations, which can translate into increased sales efforts and expanded market penetration.
Global Expansion Expansion into France and the broader European market underscores a focus on international growth, presenting opportunities to target regional research institutions and biotech companies for their genomics needs.
S2 Genomics uses 8 technology products and services including GitHub, Element UI, HubSpot, and more. Explore S2 Genomics's tech stack below.
| S2 Genomics Email Formats | Percentage |
| FirstL@s2genomics.com | 95% |
| First@s2genomics.com | 5% |
Biotechnology ResearchCalifornia, United States2-10 Employees
S2 Genomics enables automated processing of raw tissues into single cells or nuclei for genomics and cell biology studies.
S2 Genomics's revenue is estimated to be in the range of $1M$10M
S2 Genomics's revenue is estimated to be in the range of $1M$10M